The prognostic role of the cancer stem cell marker CD44 in ovarian cancer: a meta-analysis

BACKGROUND: CD44 has recently been reported as a cancer stem cell marker in ovarian cancer. However, the clinicopathological and prognostic value of this marker in ovarian cancer remains controversial; Here, we aimed to investigate the correlation between CD44 expression and the clinicopathological...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jiaying, Ding, Ding
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216581/
https://www.ncbi.nlm.nih.gov/pubmed/28070170
http://dx.doi.org/10.1186/s12935-016-0376-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216581/
https://www.ncbi.nlm.nih.gov/pubmed/28070170
http://dx.doi.org/10.1186/s12935-016-0376-4

Ejemplares similares